3M Company filings document operating results, guidance, governance, capital structure, and material corporate events for the company's diversified industrial and consumer portfolio. Form 8-K reports include quarterly earnings releases, financial-condition updates, board changes, and material agreements such as credit facilities and related guarantees.
Proxy filings describe director elections, board committee structure, executive compensation, shareholder voting matters, and governance policies. The filing record also identifies 3M's common stock and listed notes, alongside disclosures involving litigation-related adjustments, manufactured PFAS products, Solventum ownership effects, transformation costs, and other items affecting reported results and risk presentation.
3M Company (MMM) – Form 4 insider transaction dated 08/07/2025
Group President Christian T. Goralski Jr. exercised 6,650 non-qualified stock options at an exercise price of $130.14 and simultaneously sold 6,165 common shares at a market price of $150.18. Net of the sale, the executive retained 485 newly issued shares, bringing his direct beneficial ownership to 9,065 shares. All reported options from the 02/02/2017 grant are now fully settled, leaving no remaining derivative position.
The filing shows continued participation in 3M’s Employee Stock Purchase Plan and Dividend Reinvestment Plan, suggesting routine accumulation programs. While the gross sale value (~$0.93 million) exceeds the cost to exercise (~$0.87 million), the overall change represents a modest net increase in equity exposure rather than a wholesale reduction.
3M Company (MMM) has filed a Form 144 signalling a planned insider sale of common stock.
- The insider intends to sell 6,165 shares through Fidelity Brokerage Services on or after 08-07-2025.
- Based on the filing, the aggregate market value is $925,860.32, or roughly $150.2 per share.
- The stake equates to just 0.0012% of the 532.63 million shares outstanding, indicating an immaterial dilution effect.
- The shares originated from an employee stock option granted on 02-02-2016 and will be paid for in cash.
- No additional sales by the filer occurred during the past three months, and the signer affirms no undisclosed adverse information.
The filing is routine, provides transparency on a modest insider disposition, and is unlikely to affect 3M’s share price or capital structure materially.
3M Company (MMM) – Form 144 notice details a proposed insider sale of 3,477 common shares through Fidelity Brokerage Services, valued at $523,740.51 based on the filing’s reference price. The transaction is slated to begin on 05 Aug 2025 on the NYSE.
The shares equate to roughly 0.0007 % of 3M’s 532,629,702 shares outstanding, indicating an immaterial impact on the public float. The seller obtained the stock via three restricted-stock vesting events on 29 Jun 2024 (1,911 sh), 04 Feb 2025 (566 sh) and 03 May 2025 (1,000 sh). No sales were reported during the prior three-month period. Standard representations affirm the filer’s lack of undisclosed adverse information.